Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
0.0%
operating margin TTM
0.0%
revenue TTM
3.95 Thousand
revenue per share TTM
0.01$
valuation ratios | |
|---|---|
| pe ratio | -0.21 |
| peg ratio | -0.00 |
| price to book ratio | 0.74 |
| price to sales ratio | 0.00 |
| enterprise value multiple | -0.65 |
| price fair value | 0.74 |
profitability ratios | |
|---|---|
| gross profit margin | 0.0% |
| operating profit margin | 0.0% |
| pretax profit margin | 0.0% |
| net profit margin | 0.0% |
| return on assets | -108.01% |
| return on equity | -263.68% |
| return on capital employed | -143.01% |
liquidity ratios | |
|---|---|
| current ratio | 2.89 |
| quick ratio | 2.89 |
| cash ratio | 2.65 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 5,517.44 |
| cash conversion cycle | -5,517.44 |
| receivables turnover | 0.00 |
| payables turnover | 0.07 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.04 |
| debt equity ratio | 0.06 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.05 |
| interest coverage | -326.90 |
| cash flow to debt ratio | -18.55 |
cash flow ratios | |
|---|---|
| free cash flow per share | -9.16 |
| cash per share | 11.59 |
| operating cash flow per share | -9.11 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -18.55 |
| short term coverage ratios | -44.27 |
| capital expenditure coverage ratio | -185.03 |
Frequently Asked Questions
When was the last time Ernexa Therapeutics Inc. (NASDAQ:ERNA) reported earnings?
Ernexa Therapeutics Inc. (ERNA) published its most recent earnings results on 11-05-2026.
What is Ernexa Therapeutics Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Ernexa Therapeutics Inc. (NASDAQ:ERNA)'s trailing twelve months ROE is -263.68%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Ernexa Therapeutics Inc. (ERNA) currently has a ROA of -108.01%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ERNA's net profit margin stand at?
ERNA reported a profit margin of 0.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ERNA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.89 in the most recent quarter. The quick ratio stood at 2.89, with a Debt/Eq ratio of 0.06.